Aging expert Aubrey de Grey discussed how to make mice live longer and “making aging the new COVID” at Longevity Summit Dublin 2025.
Top aging biology scientist Matt Kaeberlein, PhD, debunks four myths propagated in the longevity space.
The latest data show potential for drugs with components that restore DNA molecular tagging patterns (a technique known as partial epigenetic reprogramming) across eye and liver diseases.
The senolytics dasatinib and quercetin (DQ) prevent hair graying in mice that model human skin aging.
Creatine supplementation mitigates the cognitive deficits induced by sleep deprivation in human subjects.
Study shows that rapamycin does not block exercise-driven muscle and endurance gains in female mice, though frequent dosing impairs blood sugar control.
New research provides evidence that long-term oral nicotine consumption raises NAD+ levels and preserves exploratory behaviors, similar to those seen during young ages, in older male mice.
For the first time, a longevity-associated antioxidant supplement, found in mushrooms, was revealed to improve sleep difficulties in humans.
The senolytics dasatinib and quercetin (DQ) are safe and tolerable for older adults with cognitive and motor impairments, but do they improve memory and movement?
Seragon Biosciences launched a new longevity-optimizing product, Enlivien, which neutralizes harmful, reactive molecules in the gut that have been tied to sleep deprivation.
Scientists develop a new brain aging clock based on gene expression patterns in brain tissue from 778 individuals and apply it to identify drugs that rejuvenate the brain in aged mice.
Osteoporosis — age-related bone loss — is prevented by removing (senescent) cells that promote the accumulation of Alzheimer’s proteins in old mice.
Biologist Brian Kennedy joins Peter Attia to discuss rapamycin trials, aging models, biological clocks, and lifestyle tools that may extend human healthspan.
An HIV medication, maraviroc, increases muscle size, grip strength, running speed, and running distance in aged mice.
Columbia University scientists find that inflammation increases the risk of common chronic age-related diseases only in people from industrialized populations.